Literature DB >> 19525665

Clostridium innocuum Bacteremia in a patient with acquired immunodeficiency syndrome.

Nancy Crum-Cianflone1.   

Abstract

Clostridium innocuum is an unusual cause of infections in humans. This report describes the first published case of C. innocuum bacteremia in a patient with AIDS and provides a review of the literature. The case suggests that recent C. difficile infection may be a risk factor for the subsequent development of C. innocuum bacteremia among immunosuppressed persons. Because of their intrinsic resistance to several common antibiotics, including vancomycin, C. innocuum infections are important to recognize.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19525665      PMCID： PMC2732570          DOI： 10.1097/MAJ.0b013e31819f1e95

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  12 in total

1.  Isolation of Clostridium innocuum from cases of recurrent diarrhea in patients with prior Clostridium difficile associated diarrhea.

Authors:  G Ackermann; Y J Tang; S S Jang; J Silva; A C Rodloff; S H Cohen
Journal:  Diagn Microbiol Infect Dis       Date:  2001-07       Impact factor: 2.803

2.  Clostridium innocuum, sp. n., a sporeforming anaerobe isolated from human infections.

Authors:  L D SMITH; E KING
Journal:  J Bacteriol       Date:  1962-04       Impact factor: 3.490

3.  Clostridial bacteremia in cancer patients. A 12-year experience.

Authors:  G P Bodey; S Rodriguez; V Fainstein; L S Elting
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

4.  Non-spore-forming clostridial bacteremia.

Authors:  R C Grasberger; J J Pietrafitta; P J Deckers
Journal:  J Surg Oncol       Date:  1984-03       Impact factor: 3.454

5.  Isolation of Clostridium in human infections: evaluation of 114 cases.

Authors:  S L Gorbach; H Thadepalli
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

6.  Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.

Authors:  C J Alexander; D M Citron; J S Brazier; E J Goldstein
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 7.  Clostridium innocuum endocarditis.

Authors:  A F Cutrona; C Watanakunakorn; C R Schaub; A Jagetia
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

8.  In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Mechanism of intrinsic resistance to vancomycin in Clostridium innocuum NCIB 10674.

Authors:  Véronique David; Bülent Bozdogan; Jean-Luc Mainardi; Raymond Legrand; Laurent Gutmann; Roland Leclercq
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

Review 10.  Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient.

Authors:  B Castiglioni; A Gautam; D M Citron; W Pasculle; E J C Goldstein; D Strollo; M Jordan; S Kusne
Journal:  Transpl Infect Dis       Date:  2003-12       Impact factor: 2.228
View more
  7 in total

1.  Malnutrition and microbiota--a new relationship?

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

2.  Conservation and Evolution of the Sporulation Gene Set in Diverse Members of the Firmicutes.

Authors:  Michael Y Galperin; Natalya Yutin; Yuri I Wolf; Roberto Vera Alvarez; Eugene V Koonin
Journal:  J Bacteriol       Date:  2022-05-31       Impact factor: 3.476

3.  Case-Control Study of Clostridium innocuum Infection, Taiwan.

Authors:  Yi-Ching Chen; Yi-Chun Kuo; Mi-Chi Chen; Young-Da Zhang; Chyi-Liang Chen; Puo-Hsien Le; Cheng-Hsun Chiu
Journal:  Emerg Infect Dis       Date:  2022-03       Impact factor: 6.883

4.  Association Between Human Gut Microbiome and N-Glycan Composition of Total Plasma Proteome.

Authors:  Vyacheslav A Petrov; Sodbo Zh Sharapov; Lev Shagam; Arina V Nostaeva; Marija Pezer; Dalin Li; Maja Hanić; Dermot McGovern; Edouard Louis; Souad Rahmouni; Gordan Lauc; Michel Georges; Yurii S Aulchenko
Journal:  Front Microbiol       Date:  2022-04-29       Impact factor: 5.640

5.  Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.

Authors:  Michelle I Smith; Tanya Yatsunenko; Mark J Manary; Indi Trehan; Rajhab Mkakosya; Jiye Cheng; Andrew L Kau; Stephen S Rich; Patrick Concannon; Josyf C Mychaleckyj; Jie Liu; Eric Houpt; Jia V Li; Elaine Holmes; Jeremy Nicholson; Dan Knights; Luke K Ursell; Rob Knight; Jeffrey I Gordon
Journal:  Science       Date:  2013-01-30       Impact factor: 47.728

Review 6.  Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen.

Authors:  Kathryn E Cherny; Emily B Muscat; Megan E Reyna; Larry K Kociolek
Journal:  Anaerobe       Date:  2021-07-28       Impact factor: 3.331

7.  Osteomyelitis due to Clostridium innocuum in a patient with acute lymphoblastic leukemia: case report and literature review.

Authors:  Yoshikazu Mutoh; Risen Hirai; Akira Tanimura; Takashi Matono; Eriko Morino; Satoshi Kutsuna; Maki Nagamatsu; Norio Ohmagari; Shotaro Hagiwara
Journal:  Springerplus       Date:  2015-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.